Rocket Pharmaceuticals Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Rocket Pharmaceuticals, Inc. (RCKT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-258.75-245.60-221.86-169.07-139.70-77.27-74.52
Depreciation & Amortization9.387.106.275.373.864.000.33
Stock Based Compensation43.9239.4131.0129.2418.570.000.00
Change in Working Capital1.9213.826.08-3.399.61-3.644.22
Change in Accounts Payable6.0710.159.67-4.8311.020.000.00
Change in Other Working Capital-4.153.68-3.6013.53-1.090.000.00
Other Operating Activities1.88-0.3633.7713.5351.5812.223.06
Net Cash from Operating Activities-209.72-194.92-178.14-121.16-74.64-64.66-53.79
Investing Activities
Capital Expenditures-5.86-16.44-8.36-7.7220.6123.27-1.43
Acquisitions0.000.0042.730.000.000.0076.35
Purchases of Investments137.57-81.59-103.43-245.88-67.530.000.00
Sales/Maturities of Investments383.45309.33-103.69272.44-75.98-15.74-79.81
Other Investing Activities0.00-0.04-0.26-0.10-8.450.00-0.38
Net Cash from Investing Activities131.71-98.07-69.3318.85-96.59-39.01-5.27
Financing Activities
Debt Repayment0.000.000.000.00-0.240.000.00
Common Stock Issued185.74208.40155.3437.68283.91178.10154.02
Common Stock Repurchased0.000.00-0.050.00-0.690.000.00
Other Financing Activities0.000.00-0.050.00-0.61-0.340.00
Net Cash from Financing Activities185.74208.40155.2937.68282.99177.79153.50
Summary
Net Change in Cash107.72-84.58-92.18-64.63111.7674.1294.44
Cash at Beginning of Period57.28141.86234.04298.67186.91112.7918.35
Cash at End of Period165.00-194.92141.86234.04298.67186.91112.79
Free Cash Flow-215.59-211.35-186.50-128.88-95.25-87.93-55.24
Supplemental Disclosures
Interest Paid0.000.000.000.152.962.994.49
Income Taxes Paid0.000.000.000.000.000.030.00